From: Highlighting the role of global longitudinal strain assessment in valvular heart disease
References | n | Patients | Method | Clinical application and GLS cutoff |
---|---|---|---|---|
Aortic stenosis | ||||
Vollema et al. [43] | 220 | Asymptomatic patients with severe AS | Interobserver | LV GLS was impaired despite comparable LVEF, cutoff − 18.2% |
Lafitte et al. [44] | 65 | Asymptomatic patients with severe AS | Intraobserver | To evaluate exercise tolerance and patients' outcomes, cutoff: − 18% |
Kusunose et al. [46] | 395 | Patients with severe AS preserved LVEF | Intraobserver and interobserver | LV GLS gave an additional prognostic value and predicts mortality in moderate–severe and severe AS patients, cutoff: N/A |
Ng et al. [47] | 688 | Patients with mild, moderate, and severe AS | Intraobserver and interobserver | LV GLS may be used to stratify the risk in severe AS patients and may affect the timing of valve replacement, cutoff − 14% |
Aortic regurgitation | ||||
Alashi et al. [48] | 1063 | Patients with chronic aortic regurgitation and preserved LVEF | Intraobserver and interobserver | LV GLS was related to longer-term mortality despite preserved ejection fraction, cutoff − 19.5% |
Ewe et al. [39] | 129 | Patients with moderate–severe or severe AR with preserved LVEF | interobserver | In patients with asymptomatic AR, GLS may identify the needs for surgery during follow-up, cutoff − 17.4% |
Mitral regurgitation | ||||
Mentias et al. 24 | 737 | Patients with asymptomatic primary MR and preserved LVEF | Intraobserver and interobserver | Resting LV GLS was related to mortality, cutoff − 21% |
Alashi et al. [51] | 448 | Patients with asymptomatic MR and preserved LVEF | Intraobserver and interobserver | LV GLS gave an incremental value for risk stratification, cutoff: N/A |
Kamperidis et al. [52] | 150 | Patients with severe secondary MR and none or less than mild MR | Intraobserver and interobserver | LV GLS was better than LVEF in showing LV dysfunction, cutoff: N/A |
Mitral stenosis | ||||
Gerede et al. [53] | 48 | Patients with mild-to-moderate MS | Intraobserver | GLS was able to predict MS progression, cutoff − 16.98% |